Organogenesis Holdings Inc. Class A Common Stock (ORGO) is a publicly traded Healthcare sector company. As of July 7, 2026, ORGO trades at $2.52 with a market cap of $303.67M and a P/E ratio of -16.20. ORGO moved +5.08% today. Year to date, ORGO is -52.12%; over the trailing twelve months it is -41.65%. Its 52-week range spans $2.04 to $7.08. Analyst consensus is neutral with an average price target of $3.00. Rallies surfaces ORGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ORGO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.52 |
| Market Cap | $303.67M |
| P/E Ratio | -16.20 |
| EPS | $-0.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.08 |
| 52-Week Low | $2.04 |
| Volume | 542.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $514.70M |
| Net Income | $2.72M |
| Gross Margin | 0.00% |
2 analysts cover ORGO: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.00.